Press Releases from curasan AG (20 total)
curasan AG: Dental Business Unit acquired as of June 1
Kleinostheim, Germany, June 6, 2013 – curasan AG, Germany, has acquired a large part of the “Oral Regenerative Medicine” division of Riemser Pharma GmbH, Germany,…
curasan AG now sells bone regeneration material in injectable form
Kleinostheim, 05.12.2012 – curasan AG, listed on the General Standard (ISIN: DE 000 549 453 8), has introduced its new bone regeneration material CERASORB® Ortho…
curasan AG commences operations in the European market with the appointment of a …
Kleinostheim, 15.02.2012 – curasan AG, listed in the General Standard (ISIN: DE 000 549 453 8), created a new post on 1st February 2012 in…
curasan AG: Novel bone regeneration material approved for sale in Europe
Kleinostheim, Germany – curasan AG, which is listed in the General Standard of the German Stock Exchange (ISIN: DE 000 549 453 8), has received…
curasan AG receives license for Osbone® Dental in the USA
Kleinostheim, Germany, 10th February 2011 - curasan AG, which is listed in the General Standard of the German Stock Exchange (ISIN: DE 000 549 453…
curasan AG signs sales agreement with Stryker S.A.
Kleinostheim, Germany, 9 February 2011 – curasan AG, listed in the General Standard of the German Stock Exchange (ISIN: DE 000 549 453 8), has…
curasan AG receives approval for Cerasorb® M ORTHO in Canada
Kleinostheim, Germany – curasan AG, listed in the General Standard (ISIN: DE 000 549 453 8) has received the certification for the synthetic bone regeneration…
curasan AG: Bioactive bone regeneration material approved for sale in Europe
Kleinostheim, Germany – curasan AG, listed in the General Standard of the German Stock Exchange (ISIN: DE 000 549 453 8) has received European approval…
curasan AG: Profits warning for 2010
Kleinostheim, Germany – curasan AG, listed in the General Standard (ISIN: DE 000 549 453 8) expects to make a considerable profit instead of the…
curasan AG scouts for sales partners for ATR®
Supporting wound healing and tissue regeneration through the extraction of autologous platelet-mediator-concentrate (PMC) – high patient compatibility using autologous blood – No need for centrifuges…
curasan AG: cooperation agreement for new product line
Kleinostheim, Germany, 25th May 2010 – curasan AG, listed in the General Standard of the Frankfurt Stock Exchange (ISIN: DE 000 549 453 8), has…
curasan AG: 2009 fiscal year above expectations
Kleinostheim, Germany, 6th May 2010 – curasan AG, listed in the General Standard of the German Stock Exchange (ISIN: DE 000 549 453 8), was…
curasan AG: One million units of Cerasorb® produced
Kleinostheim, Germany, 28th April 2010 – The employees of curasan AG awaited the recently produced batch of Cerasorb® M with particular excitement – because amongst…
curasan AG launches bone substitute Osbone® – the synthetic alternative witho …
Frankfurt/Kleinostheim, Germany, 16th March 2010 – In Germany alone, every year about 800,000 tooth implants are placed. In the case of almost every second patient…
curasan AG: New US subsidiary for orthopaedics
Kleinostheim, Germany, 18th February 2010 – curasan AG, listed in the General Standard of the Deutsche Börse AG (ISIN: DE 000 549 453 8), is…
Curavisc®: successful study regarding the treatment of chronic facet syndrome
A new study was presented at the 4th Annual Congress of the German Spine Society in Munich – it demonstrated the long-term effect of Curavisc®…
curasan AG signs a research agreement with Ben-Gurion University
Kleinostheim, Germany, 17th November 2009 – curasan AG, which is listed on the General Standard of the German Stock Exchange (ISIN: DE 000 549 453…
curasan AG received licence for ATR®
Kleinostheim, Germany, 16 October 2009 – curasan AG, which is listed on the General Standard of the German Stock Exchange (ISIN: DE 000 549 453…
Curavisc® after knee arthroscopy examined in clinical trial: significant reduct …
A Curavisc® trial was presented at the 58th Annual Conference of the North German Association of Orthopaedic Surgeons – proof of the safer, more effective…
Cerasorb® M used successfully during acetabular cup replacement
curasan AG presented innovative medical products from the Cerasorb® umbrella brand at the 57th annual congress of the Association of South-German Orthopaedic Surgeons (Vereinigung Süddeutscher…
Go To Page:
